MedTrace Logo

Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder

NCT03581643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 430

Last updated 2018-07-10

No results posted yet for this study

Summary

The primary aim of our study is to investigate the specificity, the sensitivity, and the overall diagnostic accuracy of the MoCA for mild and major NCD in a German-speaking population.

Secondary aims are: (1) to study the MoCA performance in different patient groups and (2) to compare the diagnostic properties of the MoCA with the ones of the MMSE (i.e., the current reference standard for screening of MCI).

Conditions

Sponsors & Collaborators

  • Andreas Monsch

    lead OTHER

Principal Investigators

  • Andreas Monsch, PhD · University Hospital, Basel, Switzerland

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-06
Primary Completion
2018-05-08
Completion
2018-05-08

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581643 on ClinicalTrials.gov